Clinical Trials Logo

Liver Diseases clinical trials

View clinical trials related to Liver Diseases.

Filter by:

NCT ID: NCT05817994 Not yet recruiting - Liver Diseases Clinical Trials

Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry

REGAL
Start date: April 2023
Phase:
Study type: Observational [Patient Registry]

Patient Registry aiming to provide regional evidence documenting the clinical merit of EUS (Endoscopic_ Ultrasound) guided liver biopsy, per local standard of practice, in patients with suspected liver disease indicated for an endoscopic intervention and a liver biopsy.

NCT ID: NCT05790109 Terminated - Liver Diseases Clinical Trials

Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.

Start date: May 23, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to assess the physician and patient experience of radio frequency (RF) track cautery in patients undergoing needle biopsy of the liver, kidney, or spleen who have one or more risk factors for biopsy-related bleeding. RF track cautery involves inserting a bipolar electrode through the same introducer needle used for the biopsy, and heating the tissues along the path of the biopsy needle to prevent bleeding. This study primarily aims to assess the operator and patient experience during the use of track cautery. Secondary aims are to assess the technical success rate and procedure adverse events. Participants who enroll in the study will undergo track cautery as part of their clinically indicated liver, kidney, or spleen biopsy. After the procedure, they will fill out a brief survey asking about their experience during the procedure. Physician operators who perform track cautery as part of the study will also fill out a survey after each procedure asking about their experience using this technique.

NCT ID: NCT05770284 Recruiting - Liver Diseases Clinical Trials

Effect of Exercise Based Regimen on Frailty in Children With Liver Disease

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

Frailty is now a well-known complication of liver disease and various studies, including pediatric literature studies, have recognized it as a poor prognostic factor in CLD as well as liver transplant settings. It is associated with poor quality of life, increased hospitalisation and mortality. Exercise for >12 weeks leads to improvements in aerobic power (peak VO2), aerobic endurance, muscle mass and strength, health related quality of life (HRQoL)(1). Although effect of Exercise on sarcopenia and frailty has been studied extensively in cirrhotic adults, there is paucity of such literature on the effect of exercise on frailty in children. Through this study, we aim to assess efficacy of exercise-based regimen on frailty in children with chronic liver disease after 12 weeks. Our secondary objective will be to compare outcome between the two groups(frail and non frail children with liver disease) and to compare change in frailty scores between the two groups. Other objectives will include assessment of the body composition analysis and the myokines and hepatokines signatures of children with liver disease (pre and post exercise intervention).

NCT ID: NCT05765253 Terminated - Vascular Diseases Clinical Trials

Achieving Portal Access With Scorpion Post-Approval Study (APASS)

Start date: July 13, 2023
Phase: N/A
Study type: Interventional

Creation of the parenchymal tract between the portal vein and the hepatic vein is the most difficult and time consuming step in a TIPS procedure. The purpose of this study is to evaluate portal vein access sets during the TIPS procedure.

NCT ID: NCT05733832 Recruiting - Liver Diseases Clinical Trials

A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease

TLC
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.

NCT ID: NCT05731908 Completed - Healthy Clinical Trials

A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

Start date: February 21, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to assess the effect of mild and moderate hepatic impairment (Child-Pugh classification A and B) on the pharmacokinetics, safety, and tolerability of BI 690517 in comparison with a control group with normal hepatic function.

NCT ID: NCT05729269 Completed - Sarcopenia Clinical Trials

Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass

Start date: March 22, 2017
Phase:
Study type: Observational

The purpose of this study was to confirm the presence of specific gut microbiota observed in patients with sarcopenia among patients who agreed to analyze gut microbiota through stool among multi-center chronic liver disease cohort patients.

NCT ID: NCT05723705 Not yet recruiting - Liver Cancer Clinical Trials

Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)

LIVEROBOT
Start date: April 2023
Phase:
Study type: Observational

LIVEROBOT is a collaboration of high-volume liver surgical centers in Europe (≥60 liver resections per year), supported by the European-African Hepato-Pancreato-Biliary Association Education Committee (E-AHPBA), and the European Registry of Minimally Invasive Liver Surgery (E-MILS) aiming to support the step-up implementation and safety of advanced surgical expertise of robotic liver surgery (RLS) on a European basis. The LIVEROBOT training program aims to promote the safe implementation of RLS throughout Europe. The data from all patients operated on during a surgeons' participation in the training program will be prospectively gathered allowing for learning curve and outcome analyses.

NCT ID: NCT05605717 Not yet recruiting - Liver Diseases Clinical Trials

Liver Fibrosis and Steatosis in dm Non Invasive Evaluation

Start date: November 1, 2022
Phase:
Study type: Observational

Non invasive evaluation of liver fibrosis and steatosis in type 2 diabetic patient in Assiut University hospitals

NCT ID: NCT05567328 Recruiting - Liver Diseases Clinical Trials

Validation of the New Vibration-guided FibroScan Examination

Start date: October 26, 2022
Phase: N/A
Study type: Interventional

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 100 adults patients will be included. The study objective is to compare the applicability between the Research FibroScan and the reference FibroScan examination performed on the liver.